ClinicalTrials.gg
Drug

Follitropin alfa clinical trials

Also written Gonal-F, Gonal F and Follitropin alpha.

studies test it
49
open now
3
in phase 3
14
first study started
2003

How each study uses follitropin alfa is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the follitropin alfa studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Sept 1997 · Gonal-f · BLA 020378 (FDA, Purple Book)
European Union
20 Oct 1995 · GONAL-f · EMEA/H/C/000071 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Follitropin alfa
11
r-hFSH
5
recombinant FSH
3
Puregon
2
Follitropin Alfa (GONAL-F)
2

Brand

Gonal-F
20
Gonal F
5

Development codes

QL1012D
1
SJ-0021
1

Other names

Follitropin alpha
5

In one entry with another drug

Given together, or one or the other

Follitropin alfa and lutropin alfa
2

Studies by the year they started

49 studies that test it; most in 2009 (5)

Studies that test follitropin alfa, by start year
YearStudies
20031
20042
20053
20061
20073
20082
20095
20101
20114
20124
20131
20155
20161
20174
20181
20214
20221
20241
20253
20262

By phase

A phase 1/2 study counts in both.

Phase 1
8
Phase 2
2
Phase 3
14
Phase 4
17
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 26 · Other 23

Merck KGaA, Darmstadt, Germany (9) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (3) · University of California, San Diego (2) · IVFarma LLC (2) · Qilu Pharmaceutical Co., Ltd. (1) · Bharat Serums and Vaccines Limited (1) · Assistance Publique - Hôpitaux de Paris (1) · EMD Serono Research & Development Institute, Inc. (1)

Often tested with

Tested in the same studies.

Lutropin alfa (8) · Menotropins (8) · Cetrorelix (2) · Follitropin delta (2) · Chorionic Gonadotropin (2) · Urofollitropin (2) · Estradiol (1) · Progesterone (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test follitropin alfa, phase 3 first.

Studies

Open first, then newest update. How each study uses follitropin alfa is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 49

See all 49 studies that test follitropin alfa →

Given beside what is tested · 19 — follitropin alfa is usual care or a partner of the new treatment
As the comparator · 23 — what is tested is compared with follitropin alfa

Showing 20 of 23.

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call follitropin alfa · ClinicalTrials.gg INT006044

  • UNII (FDA) VV3HN9ZPB5FOLLITROPIN ALFAOne source FDA
  • RxNorm 386938One source FDA
  • NCI Thesaurus C203026Follitropin AlfaOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.